Failure

U.S. Securities and Exchange Commission Establishes Momentus Stable Road Fair Fund

Retrieved on: 
Friday, April 5, 2024
Order, Failure, MAY, ALL, Summons, NOTE, Disclosure, READ, Fund, Treasury, Roger-Pol Droit, Form, Risk, THIS, YOU, Red Hot Organization, FAIR, Administration, Documentation, Plan, Fair Fund, Acquisition, Security (finance), Commission, PIPE, Sarbanes, NOT, Defense, ALSO, FUND, DEADLINE, Government, Cryptocurrency

The purpose of this Plan Notice is to inform you that you may be eligible to share in the proceeds of the Momentus Stable Road Fair Fund described herein.

Key Points: 
  • The purpose of this Plan Notice is to inform you that you may be eligible to share in the proceeds of the Momentus Stable Road Fair Fund described herein.
  • To be potentially eligible to share in the Momentus Stable Road Fair Fund, you must file a Claim Form in accordance with the steps set forth in this Plan Notice and in the Plan of Distribution (the "Plan") approved by the Securities and Exchange Commission ("SEC" or "Commission").
  • To qualify for a payment from the Momentus Stable Road Fair Fund, you must satisfy certain eligibility criteria that are described in detail in the Plan.
  • Additional Claim Forms and Plan Notices may also be downloaded at the Momentus Stable Road Fair Fund's website.

Orphan designation: (S)-2-isobutyrylamino-pentanedioic acid 5-amide 1-{[(2S,5S,8S,11R,12S,15S,18S,21R)-2,8-bis-((S)-sec-butyl)-21-hydroxy-5-(4-hydroxy-benzyl)-15-isobutyl-4,11-dimethyl-3,6,9,13,16,22-hexaoxo-10-oxa-1,4,7,14,17-pentaaza-bicyclo[16.3.1[...]

Retrieved on: 
Tuesday, April 9, 2024
Eurostat, Diagnosis, Failure, Civil service commission, Enzyme, Protease, Disease, Infection, Inflammation, Patient, Committee, Knowledge, Netherton syndrome, Regulation, EMA, IRIS, Life, Protein, Kallikrein, European, Skin, COMP, Water, Safety, European Commission, MDC, Calcineurin, Moisturizer, Steroid, Syndrome, Medicine, Pharmaceutical industry

Orphan designation: (S)-2-isobutyrylamino-pentanedioic acid 5-amide 1-{[(2S,5S,8S,11R,12S,15S,18S,21R)-2,8-bis-((S)-sec-butyl)-21-hydroxy-5-(4-hydroxy-benzyl)-15-isobutyl-4,11-dimethyl-3,6,9,13,16,22-hexaoxo-10-oxa-1,4,7,14,17-pentaaza-bicyclo[16.3.1]docos-12-yl]-amide} Treatment of Netherton syndrome, 17/10/2019 Positive

Key Points: 


Orphan designation: (S)-2-isobutyrylamino-pentanedioic acid 5-amide 1-{[(2S,5S,8S,11R,12S,15S,18S,21R)-2,8-bis-((S)-sec-butyl)-21-hydroxy-5-(4-hydroxy-benzyl)-15-isobutyl-4,11-dimethyl-3,6,9,13,16,22-hexaoxo-10-oxa-1,4,7,14,17-pentaaza-bicyclo[16.3.1]docos-12-yl]-amide} Treatment of Netherton syndrome, 17/10/2019 Positive

Agile Therapeutics Announces Delisting from Nasdaq

Retrieved on: 
Monday, March 25, 2024
Failure, OTC Markets Group, Staff, Therapy, Cryptocurrency

PRINCETON, N.J., March 25, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile Therapeutics” or the “Company”), a women's healthcare company, today announced that the Company has received a final delisting notice from Nasdaq.

Key Points: 
  • PRINCETON, N.J., March 25, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile Therapeutics” or the “Company”), a women's healthcare company, today announced that the Company has received a final delisting notice from Nasdaq.
  • The delisting is a result of failure to regain compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market set forth in Nasdaq Listing Rule 5550(b)(1) requiring companies listed on the Nasdaq Capital Market to maintain stockholder’s equity of at least $2,500,000.
  • Following the Nasdaq delisting, shares of the Company's common stock will continue to trade publicly.
  • This announcement is made in compliance with Nasdaq Listing Rule 5810(b), which requires prompt disclosure of receipt of a Staff delisting determination.

Nametag Launches Self-Service Account Recovery Solution That Stops AI-Generated Deepfake Attacks

Retrieved on: 
Monday, March 25, 2024
Failure, HubSpot, Microsoft, Organization, MFA, Risk management, IAD, Science, Partnership, Help desk, PAD, Deepfake, AI, SSPR, Atos, Okta, Machine learning, Fatigue, Zendesk

SEATTLE, March 25, 2024 (GLOBE NEWSWIRE) -- Nametag, the identity verification platform for helpdesks, today announced the launch of Nametag Autopilot, the only self-service account recovery solution that prevents AI-generated deepfake attacks. Account recovery requests represent a significant single point of failure in IT security, susceptible to ransomware, data breaches, and injection attacks, including the use of AI deepfakes. Nametag Autopilot prevents social engineering and impersonation attacks while saving organizations millions by deflecting expensive password and multifactor authentication (MFA) resets to self-service.

Key Points: 
  • HubSpot taps Nametag to secure helpdesk operations, inspire trust, and improve user experience
    SEATTLE, March 25, 2024 (GLOBE NEWSWIRE) -- Nametag , the identity verification platform for helpdesks, today announced the launch of Nametag Autopilot , the only self-service account recovery solution that prevents AI-generated deepfake attacks.
  • So when a helpdesk agent grants an account reset, they inadvertently blow the door wide open to data breaches and ransomware attacks.
  • In this way, Nametag stops account takeovers (ATOs) and data breaches by verifying users at critical moments like account recoveries, MFA resets, and high-risk transactions.
  • “I am excited about our new partnership with Nametag for its account recovery solution as it promises to elevate our customer experience to new heights.

CDMO LOSS ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Avid Bioservices, Inc. Investors to Inquire About Securities Class Action Investigation – CDMO

Retrieved on: 
Sunday, March 24, 2024
Titan, Failure, CDMO, Acceleration, News, Relevant, Bank statement, Interest, Debt-to-GDP ratio, Advertising, Security (finance)

The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

Key Points: 
  • The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=23144 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Fairfax Completes US$1 Billion Senior Notes Offering

Retrieved on: 
Friday, March 22, 2024
Failure, Risk management, Asbestos, EDGAR, Regulation, Sale, IAS 12, Insurance, TSX, Investment, Note, Annual report, Fairfax Financial, FFH, IAS, Government, Security (finance)

TORONTO, March 22, 2024 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) has completed its previously announced offering of US$1,000,000,000 in aggregate principal amount of 6.350% senior notes due 2054 (the “Notes”).

Key Points: 
  • TORONTO, March 22, 2024 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) has completed its previously announced offering of US$1,000,000,000 in aggregate principal amount of 6.350% senior notes due 2054 (the “Notes”).
  • In connection with the closing of the offering, Fairfax entered into a customary registration rights agreement.
  • Fairfax intends to use the net proceeds of this offering for general corporate purposes.
  • Such forward-looking statements may include, among other things, the intended use of the net proceeds from the offering of the Notes.

Leading the Charge in Cybersecurity: Embracing Outsourced Solutions to Navigate an Evolving Digital Landscape

Retrieved on: 
Friday, March 22, 2024
Failure, Organization, Face, Steel, Trust, Risk, LBMC, CP/M, CSO

In response to these challenges, a growing number of organizations are turning to experienced outsourcing solutions to secure their digital frontiers effectively.

Key Points: 
  • In response to these challenges, a growing number of organizations are turning to experienced outsourcing solutions to secure their digital frontiers effectively.
  • This demand often outstrips supply, leaving organizations vulnerable and in need of reliable solutions.
  • Frequent Turnover in Cybersecurity Leadership: The cybersecurity sector sees significant turnover, especially in pivotal roles such as Chief Security Officers (CSOs).
  • In light of these challenges, Van Steel , Shareholder at LBMC Cybersecurity, emphasizes the advantages of outsourced cybersecurity solutions.

Elastos Unveils BTC Oracle Enabling Dormant Bitcoin To Be Used on All Blockchains

Retrieved on: 
Friday, March 22, 2024
Elastos, Failure, EVM, ELA, ESG, Business development, ZPK, BTC, Oracle, Ecosystem, Privacy, Cryptocurrency

SINGAPORE, March 22, 2024 (GLOBE NEWSWIRE) -- Today Elastos , a pioneer in blockchain technology announces BTC Oracle, a radical new solution that will enable every EVM compatible blockchain to be a Bitcoin Layer 2, representing the most comprehensive solution for cross-chain operability enabling dormant Bitcoin to used on all Blockchains.

Key Points: 
  • SINGAPORE, March 22, 2024 (GLOBE NEWSWIRE) -- Today Elastos , a pioneer in blockchain technology announces BTC Oracle, a radical new solution that will enable every EVM compatible blockchain to be a Bitcoin Layer 2, representing the most comprehensive solution for cross-chain operability enabling dormant Bitcoin to used on all Blockchains.
  • The BTC Oracle is part of Elastos' Bitcoin Layer 2 (BeL2) , BeL2, the first Bitcoin Layer 2 to enable the direct development and management of Bitcoin-native smart contracts.
  • Elastos's Bitcoin layer 2 BTC Oracle acts as a zero-knowledge proof (ZPK) data feed that provides real-time Bitcoin information to EVM smart contracts.
  • "In that respect, BTC Oracle unlocks a 7-fold increase in the potential market for building on smart bitcoin."

Leading Proxy Advisory Firm ISS Recommends Disney Shareholders Vote “FOR” Nelson Peltz at Disney’s Annual Meeting

Retrieved on: 
Thursday, March 21, 2024
Failure, ESPN, The Walt Disney Company, Acquisition, DTC, Investment, ISS, Fox, Iger, Compensated emancipation, The Wall Street Journal, Management

NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- The Trian Group,1 which beneficially owns over $3.5 billion of common stock in The Walt Disney Company (NYSE: DIS), today announced that Institutional Shareholder Services Inc. (“ISS”), the largest and most influential proxy advisory firm, recommends that Disney shareholders vote “FOR” Nelson Peltz and “WITHHOLD” on Maria Elena Lagomasino on Trian’s BLUE proxy card in connection with Disney’s annual meeting on April 3, 2024.

Key Points: 
  • ISS recognizes that Disney has a record of “multi-year underperformance” and emphasizes the need for change on the Disney Board.
  • He could also help evaluate future capital allocation decisions.”
    “[We do] not have any concerns about [Mr. Rasulo’s] ability to serve as an objective director.”
    Maria Elena Lagomasino and Michael B.G.
  • As Disney’s annual meeting is less than two weeks away, it is important that shareholders vote TODAY.
  • Shareholders must submit their vote no later than April 2, 2024, at 11:59pm ET.

ETFS Capital Releases Letter to Fellow WisdomTree Stockholders

Retrieved on: 
Thursday, March 21, 2024
Bitcoin, Failure, Common stock, Letter, WisdomTree Investments, ETF, ALL, Sale, Hope, Disclosure, Decentralized finance, AUM, Management

NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- ETFS Capital Limited (“ETFS Capital”), the largest combined owner of common stock, $0.01 par value (the “Common Stock”), and Series A Non-Voting Convertible Preferred Stock (the “Series A Preferred Stock”) of WisdomTree, Inc. (“WisdomTree” or the “Company”) (NYSE: WT), with ownership of approximately 10.2% of the outstanding Common Stock, which together with its Series A Preferred Stock would represent approximately 18.3% of the Company’s outstanding Common Stock on an as-converted basis, today released a letter to its fellow WisdomTree shareholders, responding to a public letter from WisdomTree board of director’s (the “Board”) to ETFS Capital’s Chairman, Mr. Graham Tuckwell.

Key Points: 
  • WisdomTree Prime is and always has been a complete folly in our opinion, and in crypto ETFs the Company continues to rank towards the bottom relative to peers.
  • Consequently, WisdomTree trades at a significant discount to its intrinsic value if it were a well-run pure-play ETF business.
  • In our February 20, 2024, letter to the Board, we acknowledged that individual members of the Board and stockholders (such as ETFS Capital) have divergent views about the best way forward to unlock value at WisdomTree.
  • Fellow stockholders, over the past three years, we have attempted to address operational and governance failures through proxy campaigns.